Arena Pharmaceuticals Reports Q4 EPS of $(0.23) vs. $(0.21)

Arena Pharmaceuticals, Inc. ARNA today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments.

Arena reported a net loss in the fourth quarter of 2010 of $28.2 million, or $0.23 per share, compared to a net loss in the fourth quarter of 2009 of $29.8 million, or $0.32 per share, and a net loss in the full year ended December 31, 2010, of $124.5 million, or $1.14 per share, compared to a net loss in the full year ended December 31, 2009, of $153.2 million, or $1.82 per share.